SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001513160-13-000067
Filing Date
2013-11-06
Accepted
2013-11-06 08:25:18
Documents
3
Period of Report
2013-11-05
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 LION BIOTECHNOLOGIES CURRENT REPORT currentreport110613.htm 8-K 49763
2 CERTIFICATE OF DESIGNATION OF PREFERENCES AND RIGHTS OF SERIES A CONVERTIBLE PRE ex31.htm EX-3.1 134482
3 PRESS RELEASE ISSUED BY LION BIOTECHNOLOGIES, INC. ON NOVEMBER 6, 2013 ex991.htm EX-99.1 10004
  Complete submission text file 0001513160-13-000067.txt   195843
Mailing Address 21900 BURBANK BLVD. THIRD FLOOR WOODLAND HILLS CA 91367
Business Address 21900 BURBANK BLVD. THIRD FLOOR WOODLAND HILLS CA 91367 818-992-3126
Lion Biotechnologies, Inc. (Filer) CIK: 0001425205 (see all company filings)

IRS No.: 753254381 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-53127 | Film No.: 131194767
SIC: 4731 Arrangement of Transportation of Freight & Cargo